172 related articles for article (PubMed ID: 17451861)
1. The antitumor effects of interferon: a personal history.
Gresser I
Biochimie; 2007; 89(6-7):723-8. PubMed ID: 17451861
[TBL] [Abstract][Full Text] [Related]
2. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
Billiau A
J Pharmacol; 1983; 14 Suppl 3():105-16. PubMed ID: 6200731
[TBL] [Abstract][Full Text] [Related]
3. IFN-alpha and novel strategies of combination therapy for cancer.
Bracci L; Proietti E; Belardelli F
Ann N Y Acad Sci; 2007 Sep; 1112():256-68. PubMed ID: 17567945
[TBL] [Abstract][Full Text] [Related]
4. A critical function for type I interferons in cancer immunoediting.
Dunn GP; Bruce AT; Sheehan KC; Shankaran V; Uppaluri R; Bui JD; Diamond MS; Koebel CM; Arthur C; White JM; Schreiber RD
Nat Immunol; 2005 Jul; 6(7):722-9. PubMed ID: 15951814
[TBL] [Abstract][Full Text] [Related]
5. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
[TBL] [Abstract][Full Text] [Related]
6. [Human interferons: biological and clinical promises and premises].
Jasmin C
Schweiz Med Wochenschr; 1991 Mar; 121(13):463-6. PubMed ID: 1709521
[TBL] [Abstract][Full Text] [Related]
7. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.
Ferrantini M; Capone I; Belardelli F
Biochimie; 2007; 89(6-7):884-93. PubMed ID: 17532550
[TBL] [Abstract][Full Text] [Related]
9. Interferon research: a brief history.
Kunzi MS; Pitha PM
Methods Mol Med; 2005; 116():25-35. PubMed ID: 16000852
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations.
Fleischmann WR; Kleyn KM; Baron S
J Natl Cancer Inst; 1980 Nov; 65(5):963-6. PubMed ID: 6159498
[TBL] [Abstract][Full Text] [Related]
11. On the mechanisms of the antitumor effects of interferon.
Gresser I
Tex Rep Biol Med; 1977; 35():394-8. PubMed ID: 358464
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of the antitumor effects interferons].
Adam Z
Vnitr Lek; 1994 Jan; 40(1):56-8. PubMed ID: 7511261
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of pseudorabies virus replication by porcine alpha/beta interferon and gamma interferon in vitro.
Yao Q; Qian P; Cao Y; He Y; Si Y; Xu Z; Chen H
Eur Cytokine Netw; 2007 Jun; 18(2):71-7. PubMed ID: 17594939
[TBL] [Abstract][Full Text] [Related]
14. [Current approaches to combined treatment of recurrent respiratory papillomatosis].
Pluzhnikov MS; Riabova MA; Karpishchenko SA; Katinas EB
Vestn Otorinolaringol; 2008; (4):29-37. PubMed ID: 18837150
[No Abstract] [Full Text] [Related]
15. Different tumoricidal effects of interferon subclasses and p53 status on hepatocellular carcinoma development and neovascularization.
Noguchi R; Yoshiji H; Ikenaka Y; Kitade M; Kaji K; Yoshi J; Yanase K; Namisaki T; Yamazaki M; Tsujimoto T; Akahane T; Uemura M; Fukui H
Int J Oncol; 2008 Jan; 32(1):193-9. PubMed ID: 18097559
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of interferon-alpha 2 in therapy: structural and physiological aspects.
Kontsek P; Liptáková H; Kontseková E
Acta Virol; 1999 Feb; 43(1):63-70. PubMed ID: 10672347
[TBL] [Abstract][Full Text] [Related]
17. The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3.
Hato SV; Ricour C; Schulte BM; Lanke KH; de Bruijni M; Zoll J; Melchers WJ; Michiels T; van Kuppeveld FJ
Cell Microbiol; 2007 Dec; 9(12):2921-30. PubMed ID: 17991048
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of interferon action.
Schwarz LA; Fleischmann WR
Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
[TBL] [Abstract][Full Text] [Related]
19. Use of oromucosally administered interferon-alpha in the prevention and treatment of animal diseases.
Dec M; Puchalski A
Pol J Vet Sci; 2008; 11(2):175-86. PubMed ID: 18683548
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study of the utilization of combined interferon chemotherapy in the treatment of laryngeal cancer].
Bergler W; Bujía J
Acta Otorrinolaringol Esp; 1994; 45(6):407-10. PubMed ID: 7873228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
